Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/14/2003CA2357403A1 A pax-encoding vector and use thereof
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021266A1 The great gene and protein
03/13/2003WO2003021265A1 Genetic construct intracellular monitoring system
03/13/2003WO2003021226A2 Peptide biomarker and method of identification
03/13/2003WO2003021225A2 Method for classification of anti-psychotic drugs
03/13/2003WO2003020972A1 Molecular identification of staphylococcus-type bacteria
03/13/2003WO2003020965A2 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
03/13/2003WO2003020956A2 Nucleid acid compositions conferring herbicide resistance
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020953A2 Compositions and methods relating to colon specific genes and proteins
03/13/2003WO2003020951A2 Identification of a novel group ii intron splicing factor
03/13/2003WO2003020939A1 Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
03/13/2003WO2003020937A2 Rice regulatory sequences for gene expression in defined wheat tissue
03/13/2003WO2003020936A1 Nucleic acid compositions conferring altered metabolic characteristics
03/13/2003WO2003020934A1 Compositions and methods relating to colon specific genes and proteins
03/13/2003WO2003020933A1 Novel serine protease inhibitory protein mt0039
03/13/2003WO2003020932A1 Novel secretory proteins and dna thereof
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
03/13/2003WO2003020925A1 Methods to increase the productivity of meterologous gene expression
03/13/2003WO2003020916A2 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
03/13/2003WO2003020913A2 Anopheles gambiae odorant receptors and genes
03/13/2003WO2003020911A2 Human schizophrenia gene
03/13/2003WO2003020910A2 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL BETA-SUBUNIT, K+betaM8
03/13/2003WO2003020907A2 Histamine receptor h4 polynucleotides
03/13/2003WO2003020906A2 Multivalent protein conjugate with multiple ligand-binding domains of receptors
03/13/2003WO2003020905A2 Nucleic acid compositions conferring disease resistance
03/13/2003WO2003020903A2 Dna binding protein
03/13/2003WO2003020901A2 Compositions and methods relating to prostate specific genes and proteins
03/13/2003WO2003020900A2 Compositions and methods relating to breast specific genes and proteins
03/13/2003WO2003020899A2 Compositions and methods relating to lung specific genes and proteins
03/13/2003WO2003020897A2 Compositions and methods relating to ovary specific genes and proteins
03/13/2003WO2003020894A2 Insulin related transcription factor and uses thereof
03/13/2003WO2003020893A2 New adenovirus type 7 vectors
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020888A2 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020875A2 Staphylococci surface-exposed immunogenic polypeptides
03/13/2003WO2003020840A1 Methods for purifying insoluble bone gelatin
03/13/2003WO2003020766A1 Late gestation lung genes, fragments and uses thereof
03/13/2003WO2003020765A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
03/13/2003WO2003020764A2 Modified factor ix
03/13/2003WO2003020763A2 Soluble t cell receptor
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020761A1 Modified human growth hormone
03/13/2003WO2003020760A1 Modulation of the expression of toll-like receptors influences neurodegeneration and neuroprotection in the human central nervous system
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020758A2 Cdk regulator proteins called ringo
03/13/2003WO2003020757A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
03/13/2003WO2003020756A2 Hybrid and tandem expression of neisserial proteins
03/13/2003WO2003020755A1 Mutated env gene, mutated env glycoprotein and the use thereof
03/13/2003WO2003020754A2 Inhibition of replication factor c
03/13/2003WO2003020753A1 Peptidic compounds selectively binding to p-selectin
03/13/2003WO2003020749A2 Ncam binding compounds
03/13/2003WO2003020747A1 Modified peptides and their use for the treatment of autoimmune diseases
03/13/2003WO2003020746A1 Modified transferrin fusion proteins
03/13/2003WO2003020741A1 Nucleic acid compositions conferring altered visual phenotypes
03/13/2003WO2003020321A2 Derivatives of pseudo-peptides, their preparation and their biological uses
03/13/2003WO2003020308A1 Chicken anemia virus vaccine from cell line
03/13/2003WO2003020307A1 Bone morphogenic protein 2-induced genes and polypeptides, and their use in diagnostic and therapeutic methods
03/13/2003WO2003020223A2 A cancer treatment system
03/13/2003WO2003020213A2 Methods and compositions for treating inflammatory disorders
03/13/2003WO2003020212A2 Treatment for central nervous system disorders
03/13/2003WO2003020111A2 Alternatively spliced circulating tissue factor
03/13/2003WO2003020108A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/13/2003WO2003020025A2 Nucleic acid compositions conferring insect control in plants
03/13/2003WO2003020019A2 Methods and compositions for pearl oyster cultivation
03/13/2003WO2003020016A2 SEED SPECIFIC 7S α PROMOTER FOR EXPRESSING GENES IN PLANTS
03/13/2003WO2003020013A1 Plant-derived resistance gene
03/13/2003WO2003020005A2 Lp mammalian proteins; related reagents
03/13/2003WO2003002741A3 Nucleic acids encoding nuclear receptors
03/13/2003WO2003000847A3 Membrane associated progesterone receptor
03/13/2003WO2002102302A3 Method of preparing and formulations including hydrolyzed jojoba protein
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002094344A3 Method and apparatus for removal of insulin binding proteins (ibp) from biological fluids
03/13/2003WO2002094198A3 Modulation of cell division by an early mitotic inhibitor protein
03/13/2003WO2002085932A3 Constructs and methods for expression of recombinant hcv envelope proteins
03/13/2003WO2002083896A3 Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
03/13/2003WO2002081640A3 Gene shinc-1 and diagnostic and therapeutic uses thereof
03/13/2003WO2002081514A3 A novel f-box protein
03/13/2003WO2002079237A3 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
03/13/2003WO2002079229A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
03/13/2003WO2002078715A8 Method for induction of an antigen specific anti-inflammatory response
03/13/2003WO2002078606A3 Thrombospondin-2 and uses thereof
03/13/2003WO2002075314A8 Detection and treatment of prostate cancer
03/13/2003WO2002074976A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
03/13/2003WO2002074909A3 Cell cycle nucleic acids, polypeptides and uses thereof
03/13/2003WO2002072782A3 Master activators of pathogen responsive genes
03/13/2003WO2002070702A3 Polypeptides capable of interacting with smad polypeptide
03/13/2003WO2002070693A3 Novel abca6 transporter and uses thereof
03/13/2003WO2002070666A3 Compositions and methods for regulating autolytic processes in bacteria
03/13/2003WO2002068654A3 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
03/13/2003WO2002067996A3 Beta-endorphin/crf gene therapy for locally combating pain
03/13/2003WO2002066607A3 Compositions and methods relating to breast specific genes and proteins
03/13/2003WO2002065986A9 Transporters comprising spaced arginine moieties
03/13/2003WO2002064741A3 Compositions and methods relating to breast specific genes and proteins
03/13/2003WO2002064629A3 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
03/13/2003WO2002064091A3 Melanocortin metallopeptides for treatment of sexual dysfunction
03/13/2003WO2002063012A3 Ragweed allergens
1 ... 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 ... 2916